Article

Epigenetic heritability of cell plasticity drives cancer drug resistance through…

medRxiv · 2024 · Erica Oliveira, author Salvatore Milite, author Javier Fernandez-Mateos, author George D Cresswell, author Erika Yara-Romero, author Georgios Vlachogiannis, author Bingjie Chen, author Chela James, author Lucrezia Patruno, author Gianluca Ascolani, author Ahmet Acar, author Timon Heide, author Inma Spiteri, author Alex Graudenzi, author Giulio Caravagna, author Andrea Bertotti, author Trevor A Graham, author Luca Magnani, author Nicola Valeri, author Andrea Sottoriva, author

Key facts

Title Epigenetic heritability of cell plasticity drives cancer drug resistance through one-to-many genotype to phenotype mapping
First author Erica Oliveira, author Salvatore Milite, author Javier Fernandez-Mateos, author George D Cresswell, author Erika Yara-Romero, author Georgios Vlachogiannis, author Bingjie Chen, author Chela James, author Lucrezia Patruno, author Gianluca Ascolani, author Ahmet Acar, author Timon Heide, author Inma Spiteri, author Alex Graudenzi, author Giulio Caravagna, author Andrea Bertotti, author Trevor A Graham, author Luca Magnani, author Nicola Valeri, author Andrea Sottoriva, author
Journal medRxiv
Published Jan 1, 2024
DOI 10.1101/2023.11.15.567140
Devices mentioned BK110039, K103302
Product codes mentioned KIP, KIT, MVU, NDS, NJT, OOI, PFF, PFT, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature